（编辑 王雪儿） 证券日报网讯 12月19日晚间，英特集团发布公告称，公司十届十九次董事会会议审议通过《关于2021 年限制性股票激励计划首次授予部分第三个解除限售期解除限售条件成就的议案》《关于调整2021年限 制性股票激励计划首次授予部分回购价格的议案》等多项议案。 ...

每经AI快讯，英特集团（SZ 000411，收盘价：13.07元）12月19日晚间发布公告称，公司十届十九次董 事会临时会议于2025年12月19日以通讯表决方式召开。会议审议了《关于召开2026年第一次临时股东会 的议案》等文件。 2025年1至6月份，英特集团的营业收入构成为：医药批发业占比89.1%，医药零售业占比10.34%，其他 行业占比0.56%。 截至发稿，英特集团市值为68亿元。 每经头条（nbdtoutiao）——海南封关首日直击：为中国探路，全球最大自贸港如何重塑开放边界？ （记者 王晓波） ...

南财智讯12月19日电，大参林公告，2025年12月19日，公司收到控股股东之一柯康保先生通知，柯康保 将其质押的部分股份30,000,000股解除质押，并已完成解除质押登记手续。本次解除质押股份占柯康保 先生持有股份数的16.84%，占公司总股本的2.63%。 ...

近日该股表现 | 日期 | 当日涨跌幅（%） | 换手率（%） | 主力资金净流入（万元） | | --- | --- | --- | --- | | 2025.12.18 | 9.97 | 1.89 | 1629.16 | | 2025.12.17 | 10.01 | 18.36 | 8165.97 | | 2025.12.16 | 4.45 | 18.26 | 6426.90 | | 2025.12.15 | -1.61 | 7.45 | 1222.98 | | 2025.12.12 | 6.27 | 10.48 | 6053.09 | | 2025.12.11 | -4.71 | 8.99 | -2780.83 | | 2025.12.10 | -1.34 | 11.90 | -248.81 | | 2025.12.09 | -1.15 | 14.18 | 649.15 | | 2025.12.08 | 4.04 | 18.37 | -2327.50 | | 2025.12.05 | 6.98 | 18.18 | 11940.49 | （文章来源：证券时报网） 鹭燕医药盘中涨停，已连收3个涨停板，截至9 ...

Core Viewpoints - The current market strategy for investors is to remain calm and patient, avoiding excessive excitement from single-day rebounds or pessimism from adjustments. The focus should be on selecting fundamentally supported stocks for low-cost entry while steering clear of high-valuation stocks lacking earnings support [1][8][9] Market Overview - On Thursday, the three major indices opened lower, with the Shanghai Composite Index fluctuating to positive territory while the Shenzhen Component and ChiNext remained weak. The performance was mixed, with strong gains in the pharmaceutical and aerospace sectors, while growth and technology stocks dragged down overall market performance [4][5][6] - The Shanghai Composite Index closed at 3876.37 points, up 6.09 points, with a trading volume of 7048.96 billion; the Shenzhen Component closed at 13053.97 points, down 170.54 points, with a trading volume of 9505.87 billion; the ChiNext Index closed at 3107.06 points, down 68.85 points, with a trading volume of 4498.55 billion [5] Sector Analysis - The pharmaceutical commercial sector saw significant gains, supported by government funding announcements for medical insurance and healthcare services, totaling 416.6 billion for 2026 [6] - High-dividend stocks, particularly in the banking sector, supported the index. Investors are advised to focus on high-dividend stocks with strong fundamentals while avoiding high valuations in low-supply barrier industries [6][7] - The commercial aerospace sector became active due to recent policy clarifications and the establishment of dedicated regulatory bodies, providing a more stable development environment for the industry. Investors are encouraged to consider low-cost entries rather than chasing high prices [7]

Group 1 - A-shares are experiencing a mixed performance with major indices showing divergence, and the Shanghai Composite Index is expected to maintain a range-bound movement supported by key levels [1] - The market is anticipated to improve liquidity and trading activity due to institutional reallocation and capital inflow as the year-end approaches, potentially initiating a spring rally [1] - The focus in the short term is on the selection of the new Federal Reserve chair and the implementation of domestic monetary and fiscal policies, with geopolitical risks easing [1] Group 2 - The market is influenced by hawkish signals from the Federal Reserve, which dampens expectations for interest rate cuts, leading to adjustments in U.S. stock indices [2] - The technology sector, which had previously rebounded, is currently underperforming, and there is a recommendation to control positions in the short term [2] - In the medium to long term, factors such as improved corporate performance, increased household savings entering the market, and global liquidity easing are expected to support a "slow bull" market for A-shares in 2026 [2]

A股三大指数今日涨跌不一，截至收盘，沪指涨0.16%报3876.37点，深证成指跌1.29%，创业板指跌 2.17%，北证50跌0.51%。全市场成交额16722亿元，较上日成交额缩量1621亿元，超2800股上涨。 盘面上，医药商业板块大涨，漱玉平民、华人健康20cm涨停；商业航天产业迎来政策与技术双重催 化，相关概念股现涨停潮，顺灏股份、北摩高科、西部材料等涨停；银行股全线上涨，上海银行、渝农 银行涨超3%；IP经济、军工装备、零售板块涨幅居前。另外，海南本地股集体调整，罗牛山、海马汽 车跌超9%：元件板块持续走低，山东精密跌超6%；电池股普跌，华盛锂电跌超10%，海科新源跌超 7%。(格隆汇) ...

Core Viewpoint - The market is currently in a "light index, heavy structure" golden window period, indicating a shift in focus from overall index performance to individual stock selection and sector rotation [3]. Group 1: Market Trends - The market shows a divergence where the Shanghai Composite Index slightly increased while the Shenzhen Component and ChiNext Index declined, yet over 3,600 individual stocks rose, indicating a structural market characteristic [1]. - The morning's hot sectors include pharmaceutical commerce stimulated by early fiscal fund allocation, commercial aerospace with clear industry trends, and military electronics rebounding after adjustments, all driven by independent short-term or long-term logic [3]. Group 2: Investment Strategy - The strategy suggests focusing on strong sectors like pharmaceutical commerce and commercial aerospace, observing the strength of leading stocks and their follow-up effects, while avoiding chasing stocks at emotional peaks [4]. - For sectors that follow index adjustments but have unchanged industry logic, close monitoring is advised, especially if leading stocks show signs of stability and increased trading volume, indicating potential fund inflow [4]. - It is recommended to decisively abandon weak sectors like brokerage firms and those that are merely reacting to news, as funds will flow towards areas with sustainable logic [4]. Group 3: Stock Selection - The current market environment is seen as an optimal time to test stock selection skills and timing, shifting attention from index fluctuations to sector rotation and individual stock strength [5].

Group 1: Market Overview - A-shares showed mixed performance on December 18, with the Shanghai Composite Index rising by 0.16% to close at 3876.37 points, while the Shenzhen Component Index fell by 1.29% to 13053.97 points, and the ChiNext Index dropped by 2.17% to 3107.06 points [1] - The total trading volume in the Shanghai and Shenzhen markets was 165.55 billion yuan, a decrease of 15.57 billion yuan compared to December 17 [1] - Despite a rebound during the day, many stocks experienced significant selling pressure, indicated by long upper shadows on their candlestick charts [1] Group 2: AI Healthcare Sector - The AI healthcare sector performed strongly, led by Ant Group's announcement of the upgrade of its AI health application "Ant Aifu," which now focuses on a "health+" strategy [2] - The upgraded "Ant Aifu" app has over 15 million monthly active users, making it the largest AI health management app in China, with 55% of users coming from third-tier cities and below [2] - The emergence of successful products like "Ant Aifu" is expected to attract market funds and potentially lead to a revaluation of AI applications in vertical fields such as healthcare [2] Group 3: Local Stock Performance - In Hunan stocks, 147 stocks rose while 84 fell, with Aerospace Hanyu leading the gainers at 14.74%, and Dajia Weikang rising over 9% [3] - Dajia Weikang's main business includes the distribution and retail of pharmaceuticals, biological products, and medical devices, reporting a net profit of 5.0974 million yuan for Q3 2025, with a year-on-year decline of 86.02% [3] - The recent surge in Dajia Weikang's stock price is attributed to the positive momentum in the healthcare sector, as the company explores the feasibility of new drug developments and market opportunities [3]

人民财讯12月18日电，医疗商业概念持续走强，华人健康20%涨停，鹭燕医药、重药控股涨停，达嘉维 康、塞力医疗、漱玉平民跟涨。 近期，蚂蚁集团宣布，将其旗下的AI健康应用"AQ"正式升级为"蚂蚁阿福"。这个月活用户已超过1500 万的健康助手，不再仅仅是一个工具，它被重新定位为"AI健康朋友"，旨在深度融入用户的日常健康管 理。 资本市场对此反应迅速。就在公告发布后，A股医药商业板块应声而起，领涨两市，多只个股涨停。 01 现象：AI健康应用引爆板块行情 市场情绪被一则科技新闻瞬间点燃。2025年12月18日，蚂蚁集团正式将其AI健康应用品牌升级为"蚂蚁 阿福"。 新版"阿福"的核心升级在于增加了"健康陪伴"功能板块，并强化了健康问答与服务。它可以通过连接各 类智能设备、记录健康数据、设定健康目标等方式，像朋友一样陪伴用户养成健康习惯。 这一战略升级，被市场解读为科技巨头加码"医疗+AI"生态的重要信号。当日，A股医药商业板块反应 剧烈。 截至早盘收盘，板块整体上涨4.22%。个股方面，华人健康收获20%的涨停板，漱玉平民涨超10%，英 特集团、塞力医疗、鹭燕医药、重药控股等多只股票涨停。 02 深层逻辑：医 ...